BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21220252)

  • 1. Can beta-blockers be used for people with COPD?
    Drug Ther Bull; 2011 Jan; 49(1):2-5. PubMed ID: 21220252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of beta-blockers in patients with COPD.
    Andrus MR; Holloway KP; Clark DB
    Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
    Bułdak Ł; Duława A; Krysiak R; Okopień B
    Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C; Tudorache V; Oancea C
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.
    Egred M; Shaw S; Mohammad B; Waitt P; Rodrigues E
    QJM; 2005 Jul; 98(7):493-7. PubMed ID: 15955798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
    Chang CL; Mills GD; McLachlan JD; Karalus NC; Hancox RJ
    Intern Med J; 2010 Mar; 40(3):193-200. PubMed ID: 19383058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the use of beta-blockers in COPD still an unresolved dilemma?
    Foresi A; Cavigioli G; Signorelli G; Pozzoni MB; Olivieri D
    Respiration; 2010; 80(3):177-87. PubMed ID: 20639691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
    Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
    J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical inquiries. Do beta-blockers worsen respiratory status for patients with COPD?
    Baselli LM; Oswald MA; Nashelsky JM
    J Fam Pract; 2005 May; 54(5):472-3. PubMed ID: 15865911
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality.
    Mascarenhas J; Azevedo A; Bettencourt P
    Curr Opin Pulm Med; 2010 Mar; 16(2):106-11. PubMed ID: 20042977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-blockers usage in cardio-vascular diseases co-existing with COPD].
    Walczak D; Kowal A; Jankowska R
    Pol Merkur Lekarski; 2012 Dec; 33(198):338-41. PubMed ID: 23437704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease].
    Di Tano G; Frattini S; Pirelli S
    G Ital Cardiol (Rome); 2011 Sep; 12(9):588-95. PubMed ID: 21892219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with beta blockers in people with COPD.
    Kazani S; Israel E
    BMJ; 2011 May; 342():d2655. PubMed ID: 21558358
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of beta-blockers in patients with COPD: current perspective.
    Malerba M; Montuschi P; Radaeli A; Pirisi M
    Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.